Stockwatch: Big Pharma Buys Bargain-Basement Big Biotech
AstraZeneca’s Acquisition Of Alexion May Not Be The Last
Executive Summary
The acquisitions of Alexion and Celgene are the latest in a long line of transactions in which big pharma buys big biotech. But these latest two are of biotechs that have disappointed their investors, and there are still some of those left for 2021.